View the PHORUXO registration information details.
Back to drug list
ItemsDrug Registration information
ID983
No983
Brand NamePHORUXO
IngredientsRUXOLITINIB 1.5 %
Dosage FormCREAM
Primary PackagingTUBE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 30 G/TUBE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TOPICAL SHORT TERM AND NON CONTINUOUS CHRONIC TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON-IMMUNOCOMPROMISED PATIENTS 12 YEARS AGE AND OLDER WHOSE DISEASE IS NOT ADEQUATELY CONTROLLED WITH TOPICAL PRESCRIPTION THERAPIES
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE, HOMOGENEOUS CREAM
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY No.2
CountryLAO PDR
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 0950/23
FDD Registration Date17/03/2023
Expiry Date16/03/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA